Literature DB >> 20167394

[Evaluation of the anxiety state in patients receiving radioiodine treatment or who undergo a sentinel lymph node examination in the Nuclear Medicine Department].

A Domènech1, P Notta, A Benítez, D Ramal, L Rodríguez-Bel, C Massuet, J Martín-Comín.   

Abstract

OBJECTIVE: To analyze the presence of anxiety in patients referred to a Nuclear Medicine Department (NMD).
MATERIAL AND METHODS: A total of 148 patients were included: 67 were referred for radioiodine therapy, 48 with hyperthyroidism (HT), 19 with differentiated thyroid carcinoma (DTC), and 81 were referred for detection and biopsy of the sentinel node in breast cancer (BC). The following documents were filled out: personal data, a state-trait anxiety inventory, a scale of pre-disposing factors causing anxiety and an information questionnaire. Anxiety-predisposing factors and the influence of the information on the presence of anxiety were studied.
RESULTS: HT patients: 47% had anxiety in the moment of the visit that was not related to the level of information received. The factor that worried them the most was the radioiodine administration. Being the first visit to a NMD significantly influenced (p<0.05) on the presence of anxiety. DTC patients: 42% had anxiety in the moment of the visit not related to the level of information received. The factor that worried them the most was the illness itself. No factor had a significant influence on the presence of anxiety. BC patients: 53% had anxiety in the moment of the visit that was not related to the level of information received. What worried them the most were the results. Having anxiety and/or depression significantly influenced (p<0.05) the presence of anxiety.
CONCLUSION: The quantity of information given before a procedure in a NMD does not influence on the presence of anxiety. Nevertheless, it is our duty to give the best possible information. Copyright 2009 Elsevier España, S.L. y SEMNIM. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167394     DOI: 10.1016/j.remn.2009.12.009

Source DB:  PubMed          Journal:  Rev Esp Med Nucl        ISSN: 0212-6982


  6 in total

Review 1.  Effectiveness of educational videos on patient's preparation for diagnostic procedures: Systematic review and Meta-Analysis.

Authors:  Ana Monteiro Grilo; Ana Catarina Ferreira; Marta Pedro Ramos; Elisabete Carolino; Ana Filipa Pires; Lina Vieira
Journal:  Prev Med Rep       Date:  2022-07-05

2.  Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study.

Authors:  Giuseppe Lo Re; Rossella De Luca; Filippa Muscarneri; Patrizia Dorangricchia; Dario Picone; Federica Vernuccio; Sergio Salerno; Giuseppe La Tona; Antonio Pinto; Massimo Midiri; Antonio Russo; Roberto Lagalla; Giuseppe Cicero
Journal:  Radiol Med       Date:  2016-06-22       Impact factor: 3.469

3.  Assessment of Residual Radioactivity by a Comprehensive Wireless, Wearable Device in Thyroid Cancer Patients Undergoing Radionuclide Therapy and Comparison With the Results of a Home Device: A Feasibility Study.

Authors:  R Gallicchio; D Scapicchio; A Nardelli; T Pellegrino; M Prisco; P Mainenti; C Sirignano; P Pedicini; G Storto
Journal:  IEEE J Transl Eng Health Med       Date:  2020-12-02       Impact factor: 3.316

4.  Anxiety in Cancer Patients during 18F-FDG PET/CT Low Dose: A Comparison of Anxiety Levels before and after Imaging Studies.

Authors:  Ana Grilo; Lina Vieira; Elisabete Carolino; Cátia Oliveira; Carolina Pacheco; Maria Castro; Juan Alonso
Journal:  Nurs Res Pract       Date:  2017-03-14

5.  Psychological impact of 131I radioprotection measures on thyroid cancer patients.

Authors:  Elena Barbus; Claudiu Pestean; Maria Iulia Larg; Katalin Gabora; Eduard-Alexandru Bonci; Claudiu Badulescu; Andra Piciu
Journal:  Clujul Med       Date:  2018-10-30

6.  Oncological Patient Anxiety in Imaging Studies: the PET/CT Example.

Authors:  Carla Abreu; Ana Grilo; Filipa Lucena; Elisabete Carolino
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.